Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.002 USD | +0.20% | +4.38% | -19.84% |
03-21 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
03-21 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 5.48M 7.49M | Sales 2025 * | 3.27M 4.47M | Capitalization | 60.1M 82.17M |
---|---|---|---|---|---|
Net income 2024 * | -85M -116M | Net income 2025 * | -94M -129M | EV / Sales 2024 * | 5.4 x |
Net cash position 2024 * | 30.52M 41.73M | Net Debt 2025 * | 25.18M 34.43M | EV / Sales 2025 * | 26.1 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-0.58
x | Employees | 63 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.5% |
Latest transcript on Kronos Bio, Inc.
1 day | +2.00% | ||
1 week | +4.38% | ||
Current month | -22.92% | ||
1 month | -27.39% | ||
3 months | -15.08% | ||
6 months | +17.88% | ||
Current year | -19.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 18-03-31 | |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
David Tanen
FOU | Founder | 52 | 17-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Tanen
FOU | Founder | 52 | 17-06-01 |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
Arie Belldegrun
FOU | Founder | 74 | 17-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.002 | +0.20% | 59 893 |
24-04-26 | 1 | +2.04% | 442,883 |
24-04-25 | 0.98 | +2.08% | 765,478 |
24-04-24 | 0.96 | +1.05% | 904,416 |
24-04-23 | 0.95 | -1.04% | 4,308,192 |
Delayed Quote Nasdaq, April 29, 2024 at 10:23 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.84% | 60.1M | |
+2.62% | 42.75B | |
+47.70% | 41.61B | |
+12.39% | 41.34B | |
-12.36% | 26.59B | |
+8.37% | 25.49B | |
-23.28% | 18.12B | |
+30.45% | 12.24B | |
-1.90% | 11.76B | |
+7.78% | 11B |
- Stock Market
- Equities
- KRON Stock